Home » DOWPHARMA SIGNS FOURTH DEAL FOR PFENEX TECHNOLOGY
DOWPHARMA SIGNS FOURTH DEAL FOR PFENEX TECHNOLOGY
Contract manufacturing services provider Dowpharma, has signed a collaboration agreement for its Pfenex Expression Technology, its fourth agreement in 1Q 2006, signifying the technology's popularity in developing new vaccines and biotherapeutics products.
DrugResearcher.com
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May